Nitrosamine Testing
Product
Information
Ensuring Pharmaceutical Safety and Compliance Nitrosamines can form during the manufacturing process of active pharmaceutical ingredients (APIs) and drug products. Because of their potential carcinogenic properties, nitrosamine impurities pose significant health risks to patients. Regulatory bodies like the FDA and EMA have set strict rules to manage these impurities. This makes nitrosamine risk assessments and testing vital for compliance and patient safety. Learn more here: https://www.cambrex.com/analytical-services/analytical-testing/nitrosamine-testing/
Supplied From
United States
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Laboratory and Analytical Services
